Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBP-201 in chronic rhinosinusitis with nasal polyps
CTR20211887Phase 2Terminated
- Sponsor
- Connect Biopharma
- Start
- Aug 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of rademikibart in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Connect Biopharma. Started Aug 2021; status: terminated.
02
Drugs
rademikibart
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on CTR20211887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211887.